Global Sabin Inactivated Polio vaccine (sIPV) Market Growth 2026-2032
The global Sabin Inactivated Polio vaccine (sIPV) market size is predicted to grow from US$ 1147 million in 2025 to US$ 1582 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.
Sabin Inactivated Polio Vaccine (sIPV), produced in Vero cells, is a preventive biological product manufactured using Sabin attenuated strains of poliovirus types I, II, and III as seed viruses. It is produced through Vero cell culture, virus harvest, purification, inactivation, formulation, and filling processes. Administered by injection, it induces active immunity against polioviruses and helps prevent poliomyelitis-related infection and transmission risks. Compared with conventional wild-strain inactivated polio vaccines, sIPV uses attenuated strains as production viruses, offering strategic value in manufacturing biosafety, industrial accessibility, and long-term supply security during the final stage of global polio eradication. It is not only an important technology route for national immunization program upgrading, but also a key product supporting the transition from oral live attenuated vaccines toward inactivated vaccines and combination vaccine systems, representing a higher-end direction for vaccine safety, sustainable supply, and public health value.In 2025, global Sabin Inactivated Polio Vaccine production reached approximately 586.15 million units.The average gross profit margin of this product is 75%.
The market opportunities for Sabin Inactivated Polio Vaccine (sIPV), produced in Vero cells, are driven by the late-stage global polio eradication agenda, continuous optimization of immunization strategies, and the need for safer vaccine supply. As countries gradually reduce reliance on oral live attenuated polio vaccines, inactivated polio vaccines are gaining strategic importance in primary immunization, sequential schedules, and long-term population protection. China has incorporated an IPV and bOPV sequential schedule into routine immunization, reflecting the national immunization program?s emphasis on the safety and sustainability of inactivated vaccines. Because sIPV is produced using Sabin attenuated strains rather than wild poliovirus strains, it is more aligned with biosafety and scalable production requirements, making it suitable for public health procurement, international organization supply, and immunization programs in developing countries. For manufacturers, sIPV is not merely a single vaccine product, but a strategic entry point linking primary immunization, combination vaccine development, global supply chain cooperation, and public health brand value.
The industry?s challenges are concentrated in high technical barriers, quality consistency, regulatory requirements, and cost control. sIPV production involves virus seed management, Vero cell culture, virus purification, inactivation validation, antigen content control, sterility assurance, and batch-to-batch consistency. Each step directly affects vaccine safety, immunogenicity, and release stability. Vaccines are highly regulated and high-responsibility products, requiring manufacturers to continuously meet drug registration, GMP, batch release, cold-chain transportation, and post-marketing surveillance requirements. Any quality fluctuation may affect supply continuity and brand credibility. At the same time, polio vaccines have a strong public-goods attribute, meaning that pricing space, government procurement cycles, international certification, capacity utilization, and raw material supply security all influence profitability. Future competition will not be limited to production capacity, but will depend more on process platforms, quality systems, and global compliance capability.
Downstream demand is shifting from traditional monovalent vaccine use toward stable immunization program supply, combination vaccine upgrading, and international public health procurement. Public health systems focus more on product safety, stable supply, batch traceability, and quality assurance suitable for large-scale vaccination. Disease control and vaccination institutions require products with stable dosage forms, cold-chain friendliness, clear vaccination procedures, and smooth compatibility with existing immunization schedules. As demand rises for more convenient pediatric vaccination, IPV-containing combination vaccines will become an important direction for reducing injection burden, improving compliance, and enhancing product value. Internationally, long-term immune barriers will still be needed in the late and post-eradication stages of polio control. With its biosafety advantages and cost optimization potential, sIPV has long-term potential to enter global immunization supply systems.
LP Information, Inc. (LPI) ' newest research report, the ?Sabin Inactivated Polio vaccine (sIPV) Industry Forecast? looks at past sales and reviews total world Sabin Inactivated Polio vaccine (sIPV) sales in 2025, providing a comprehensive analysis by region and market sector of projected Sabin Inactivated Polio vaccine (sIPV) sales for 2026 through 2032. With Sabin Inactivated Polio vaccine (sIPV) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sabin Inactivated Polio vaccine (sIPV) industry.
This Insight Report provides a comprehensive analysis of the global Sabin Inactivated Polio vaccine (sIPV) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sabin Inactivated Polio vaccine (sIPV) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Sabin Inactivated Polio vaccine (sIPV) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sabin Inactivated Polio vaccine (sIPV) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sabin Inactivated Polio vaccine (sIPV).
This report presents a comprehensive overview, market shares, and growth opportunities of Sabin Inactivated Polio vaccine (sIPV) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Sabin Inactivated Polio vaccine (sIPV) market?
What factors are driving Sabin Inactivated Polio vaccine (sIPV) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sabin Inactivated Polio vaccine (sIPV) market opportunities vary by end market size?
How does Sabin Inactivated Polio vaccine (sIPV) break out by Type, by Application?
Sabin Inactivated Polio Vaccine (sIPV), produced in Vero cells, is a preventive biological product manufactured using Sabin attenuated strains of poliovirus types I, II, and III as seed viruses. It is produced through Vero cell culture, virus harvest, purification, inactivation, formulation, and filling processes. Administered by injection, it induces active immunity against polioviruses and helps prevent poliomyelitis-related infection and transmission risks. Compared with conventional wild-strain inactivated polio vaccines, sIPV uses attenuated strains as production viruses, offering strategic value in manufacturing biosafety, industrial accessibility, and long-term supply security during the final stage of global polio eradication. It is not only an important technology route for national immunization program upgrading, but also a key product supporting the transition from oral live attenuated vaccines toward inactivated vaccines and combination vaccine systems, representing a higher-end direction for vaccine safety, sustainable supply, and public health value.In 2025, global Sabin Inactivated Polio Vaccine production reached approximately 586.15 million units.The average gross profit margin of this product is 75%.
The market opportunities for Sabin Inactivated Polio Vaccine (sIPV), produced in Vero cells, are driven by the late-stage global polio eradication agenda, continuous optimization of immunization strategies, and the need for safer vaccine supply. As countries gradually reduce reliance on oral live attenuated polio vaccines, inactivated polio vaccines are gaining strategic importance in primary immunization, sequential schedules, and long-term population protection. China has incorporated an IPV and bOPV sequential schedule into routine immunization, reflecting the national immunization program?s emphasis on the safety and sustainability of inactivated vaccines. Because sIPV is produced using Sabin attenuated strains rather than wild poliovirus strains, it is more aligned with biosafety and scalable production requirements, making it suitable for public health procurement, international organization supply, and immunization programs in developing countries. For manufacturers, sIPV is not merely a single vaccine product, but a strategic entry point linking primary immunization, combination vaccine development, global supply chain cooperation, and public health brand value.
The industry?s challenges are concentrated in high technical barriers, quality consistency, regulatory requirements, and cost control. sIPV production involves virus seed management, Vero cell culture, virus purification, inactivation validation, antigen content control, sterility assurance, and batch-to-batch consistency. Each step directly affects vaccine safety, immunogenicity, and release stability. Vaccines are highly regulated and high-responsibility products, requiring manufacturers to continuously meet drug registration, GMP, batch release, cold-chain transportation, and post-marketing surveillance requirements. Any quality fluctuation may affect supply continuity and brand credibility. At the same time, polio vaccines have a strong public-goods attribute, meaning that pricing space, government procurement cycles, international certification, capacity utilization, and raw material supply security all influence profitability. Future competition will not be limited to production capacity, but will depend more on process platforms, quality systems, and global compliance capability.
Downstream demand is shifting from traditional monovalent vaccine use toward stable immunization program supply, combination vaccine upgrading, and international public health procurement. Public health systems focus more on product safety, stable supply, batch traceability, and quality assurance suitable for large-scale vaccination. Disease control and vaccination institutions require products with stable dosage forms, cold-chain friendliness, clear vaccination procedures, and smooth compatibility with existing immunization schedules. As demand rises for more convenient pediatric vaccination, IPV-containing combination vaccines will become an important direction for reducing injection burden, improving compliance, and enhancing product value. Internationally, long-term immune barriers will still be needed in the late and post-eradication stages of polio control. With its biosafety advantages and cost optimization potential, sIPV has long-term potential to enter global immunization supply systems.
LP Information, Inc. (LPI) ' newest research report, the ?Sabin Inactivated Polio vaccine (sIPV) Industry Forecast? looks at past sales and reviews total world Sabin Inactivated Polio vaccine (sIPV) sales in 2025, providing a comprehensive analysis by region and market sector of projected Sabin Inactivated Polio vaccine (sIPV) sales for 2026 through 2032. With Sabin Inactivated Polio vaccine (sIPV) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sabin Inactivated Polio vaccine (sIPV) industry.
This Insight Report provides a comprehensive analysis of the global Sabin Inactivated Polio vaccine (sIPV) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sabin Inactivated Polio vaccine (sIPV) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Sabin Inactivated Polio vaccine (sIPV) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sabin Inactivated Polio vaccine (sIPV) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sabin Inactivated Polio vaccine (sIPV).
This report presents a comprehensive overview, market shares, and growth opportunities of Sabin Inactivated Polio vaccine (sIPV) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Vials
- Syringes
- Monovalent
- Bivalent
- Trivalent
- Multivalent
- Vero Cell
- Human Diploid
- Primary Cell
- Recombinant
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- GSK
- Serum Institute of India
- Bharat Biotech
- Bilthoven Biologicals
- Bio Farma
- Panacea Biotec
- Sinovac
- Beijing Tiantan Biological
- IMBCAMS
What is the 10-year outlook for the global Sabin Inactivated Polio vaccine (sIPV) market?
What factors are driving Sabin Inactivated Polio vaccine (sIPV) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sabin Inactivated Polio vaccine (sIPV) market opportunities vary by end market size?
How does Sabin Inactivated Polio vaccine (sIPV) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Sabin Inactivated Polio vaccine (sIPV) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Sabin Inactivated Polio vaccine (sIPV) by Country/Region, 2021, 2025 & 2032
2.2 Sabin Inactivated Polio vaccine (sIPV) Segment by Type
2.2.1 Vials
2.2.2 Syringes
2.2.3 Sabin Inactivated Polio vaccine (sIPV) Sales by Type
2.2.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Type (2021-2026)
2.3 Sabin Inactivated Polio vaccine (sIPV) Segment by Valency
2.3.1 Monovalent
2.3.2 Bivalent
2.3.3 Trivalent
2.3.4 Multivalent
2.3.5 Sabin Inactivated Polio vaccine (sIPV) Sales by Valency
2.3.5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Valency (2021-2026)
2.3.5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Valency (2021-2026)
2.3.5.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Valency (2021-2026)
2.4 Sabin Inactivated Polio vaccine (sIPV) Segment by Production Cell
2.4.1 Vero Cell
2.4.2 Human Diploid
2.4.3 Primary Cell
2.4.4 Recombinant
2.4.5 Sabin Inactivated Polio vaccine (sIPV) Sales by Production Cell
2.4.5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Production Cell (2021-2026)
2.4.5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Production Cell (2021-2026)
2.4.5.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Production Cell (2021-2026)
2.5 Sabin Inactivated Polio vaccine (sIPV) Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Others
2.5.4 Sabin Inactivated Polio vaccine (sIPV) Sales by Application
2.5.4.1 Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Sabin Inactivated Polio vaccine (sIPV) Breakdown Data by Company
3.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Company (2021-2026)
3.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company (2021-2026)
3.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Company (2021-2026)
3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Company (2021-2026)
3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company (2021-2026)
3.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Company
3.4 Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Product Location Distribution
3.4.2 Players Sabin Inactivated Polio vaccine (sIPV) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SABIN INACTIVATED POLIO VACCINE (SIPV) BY GEOGRAPHIC REGION
4.1 World Historic Sabin Inactivated Polio vaccine (sIPV) Market Size by Geographic Region (2021-2026)
4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sabin Inactivated Polio vaccine (sIPV) Market Size by Country/Region (2021-2026)
4.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sabin Inactivated Polio vaccine (sIPV) Sales Growth
4.4 APAC Sabin Inactivated Polio vaccine (sIPV) Sales Growth
4.5 Europe Sabin Inactivated Polio vaccine (sIPV) Sales Growth
4.6 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Growth
5 AMERICAS
5.1 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country
5.1.1 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026)
5.1.2 Americas Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026)
5.2 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
5.3 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region
6.1.1 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2021-2026)
6.1.2 APAC Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2021-2026)
6.2 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
6.3 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sabin Inactivated Polio vaccine (sIPV) by Country
7.1.1 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026)
7.1.2 Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026)
7.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
7.3 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) by Country
8.1.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026)
8.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
8.3 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sabin Inactivated Polio vaccine (sIPV)
10.3 Manufacturing Process Analysis of Sabin Inactivated Polio vaccine (sIPV)
10.4 Industry Chain Structure of Sabin Inactivated Polio vaccine (sIPV)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
11.3 Sabin Inactivated Polio vaccine (sIPV) Customer
12 WORLD FORECAST REVIEW FOR SABIN INACTIVATED POLIO VACCINE (SIPV) BY GEOGRAPHIC REGION
12.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size Forecast by Region
12.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Region (2027-2032)
12.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Type (2027-2032)
12.7 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.1.3 Sanofi Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.2.3 GSK Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.3.3 Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 Bharat Biotech
13.4.1 Bharat Biotech Company Information
13.4.2 Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.4.3 Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bharat Biotech Main Business Overview
13.4.5 Bharat Biotech Latest Developments
13.5 Bilthoven Biologicals
13.5.1 Bilthoven Biologicals Company Information
13.5.2 Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.5.3 Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bilthoven Biologicals Main Business Overview
13.5.5 Bilthoven Biologicals Latest Developments
13.6 Bio Farma
13.6.1 Bio Farma Company Information
13.6.2 Bio Farma Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.6.3 Bio Farma Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bio Farma Main Business Overview
13.6.5 Bio Farma Latest Developments
13.7 Panacea Biotec
13.7.1 Panacea Biotec Company Information
13.7.2 Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.7.3 Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Panacea Biotec Main Business Overview
13.7.5 Panacea Biotec Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.8.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Beijing Tiantan Biological
13.9.1 Beijing Tiantan Biological Company Information
13.9.2 Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.9.3 Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Tiantan Biological Main Business Overview
13.9.5 Beijing Tiantan Biological Latest Developments
13.10 IMBCAMS
13.10.1 IMBCAMS Company Information
13.10.2 IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.10.3 IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 IMBCAMS Main Business Overview
13.10.5 IMBCAMS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Sabin Inactivated Polio vaccine (sIPV) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Sabin Inactivated Polio vaccine (sIPV) by Country/Region, 2021, 2025 & 2032
2.2 Sabin Inactivated Polio vaccine (sIPV) Segment by Type
2.2.1 Vials
2.2.2 Syringes
2.2.3 Sabin Inactivated Polio vaccine (sIPV) Sales by Type
2.2.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Type (2021-2026)
2.3 Sabin Inactivated Polio vaccine (sIPV) Segment by Valency
2.3.1 Monovalent
2.3.2 Bivalent
2.3.3 Trivalent
2.3.4 Multivalent
2.3.5 Sabin Inactivated Polio vaccine (sIPV) Sales by Valency
2.3.5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Valency (2021-2026)
2.3.5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Valency (2021-2026)
2.3.5.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Valency (2021-2026)
2.4 Sabin Inactivated Polio vaccine (sIPV) Segment by Production Cell
2.4.1 Vero Cell
2.4.2 Human Diploid
2.4.3 Primary Cell
2.4.4 Recombinant
2.4.5 Sabin Inactivated Polio vaccine (sIPV) Sales by Production Cell
2.4.5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Production Cell (2021-2026)
2.4.5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Production Cell (2021-2026)
2.4.5.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Production Cell (2021-2026)
2.5 Sabin Inactivated Polio vaccine (sIPV) Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Others
2.5.4 Sabin Inactivated Polio vaccine (sIPV) Sales by Application
2.5.4.1 Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Sabin Inactivated Polio vaccine (sIPV) Breakdown Data by Company
3.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Company (2021-2026)
3.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company (2021-2026)
3.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Company (2021-2026)
3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Company (2021-2026)
3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company (2021-2026)
3.3 Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Company
3.4 Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Product Location Distribution
3.4.2 Players Sabin Inactivated Polio vaccine (sIPV) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SABIN INACTIVATED POLIO VACCINE (SIPV) BY GEOGRAPHIC REGION
4.1 World Historic Sabin Inactivated Polio vaccine (sIPV) Market Size by Geographic Region (2021-2026)
4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sabin Inactivated Polio vaccine (sIPV) Market Size by Country/Region (2021-2026)
4.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sabin Inactivated Polio vaccine (sIPV) Sales Growth
4.4 APAC Sabin Inactivated Polio vaccine (sIPV) Sales Growth
4.5 Europe Sabin Inactivated Polio vaccine (sIPV) Sales Growth
4.6 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Growth
5 AMERICAS
5.1 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country
5.1.1 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026)
5.1.2 Americas Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026)
5.2 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
5.3 Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region
6.1.1 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2021-2026)
6.1.2 APAC Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2021-2026)
6.2 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
6.3 APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sabin Inactivated Polio vaccine (sIPV) by Country
7.1.1 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026)
7.1.2 Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026)
7.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
7.3 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) by Country
8.1.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026)
8.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026)
8.3 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sabin Inactivated Polio vaccine (sIPV)
10.3 Manufacturing Process Analysis of Sabin Inactivated Polio vaccine (sIPV)
10.4 Industry Chain Structure of Sabin Inactivated Polio vaccine (sIPV)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
11.3 Sabin Inactivated Polio vaccine (sIPV) Customer
12 WORLD FORECAST REVIEW FOR SABIN INACTIVATED POLIO VACCINE (SIPV) BY GEOGRAPHIC REGION
12.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size Forecast by Region
12.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Region (2027-2032)
12.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Type (2027-2032)
12.7 Global Sabin Inactivated Polio vaccine (sIPV) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.1.3 Sanofi Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.2.3 GSK Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.3.3 Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 Bharat Biotech
13.4.1 Bharat Biotech Company Information
13.4.2 Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.4.3 Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bharat Biotech Main Business Overview
13.4.5 Bharat Biotech Latest Developments
13.5 Bilthoven Biologicals
13.5.1 Bilthoven Biologicals Company Information
13.5.2 Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.5.3 Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Bilthoven Biologicals Main Business Overview
13.5.5 Bilthoven Biologicals Latest Developments
13.6 Bio Farma
13.6.1 Bio Farma Company Information
13.6.2 Bio Farma Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.6.3 Bio Farma Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bio Farma Main Business Overview
13.6.5 Bio Farma Latest Developments
13.7 Panacea Biotec
13.7.1 Panacea Biotec Company Information
13.7.2 Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.7.3 Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Panacea Biotec Main Business Overview
13.7.5 Panacea Biotec Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.8.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Beijing Tiantan Biological
13.9.1 Beijing Tiantan Biological Company Information
13.9.2 Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.9.3 Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Tiantan Biological Main Business Overview
13.9.5 Beijing Tiantan Biological Latest Developments
13.10 IMBCAMS
13.10.1 IMBCAMS Company Information
13.10.2 IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
13.10.3 IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 IMBCAMS Main Business Overview
13.10.5 IMBCAMS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sabin Inactivated Polio vaccine (sIPV) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sabin Inactivated Polio vaccine (sIPV) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vials
Table 4. Major Players of Syringes
Table 5. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 6. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Table 7. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2021-2026)
Table 9. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Monovalent
Table 11. Major Players of Bivalent
Table 12. Major Players of Trivalent
Table 13. Major Players of Multivalent
Table 14. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Valency (2021-2026) & (K Dose)
Table 15. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Valency (2021-2026)
Table 16. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Valency (2021-2026) & ($ million)
Table 17. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Valency (2021-2026)
Table 18. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Valency (2021-2026) & (US$/Unit)
Table 19. Major Players of Vero Cell
Table 20. Major Players of Human Diploid
Table 21. Major Players of Primary Cell
Table 22. Major Players of Recombinant
Table 23. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Production Cell (2021-2026) & (K Dose)
Table 24. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Production Cell (2021-2026)
Table 25. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Production Cell (2021-2026) & ($ million)
Table 26. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Production Cell (2021-2026)
Table 27. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Production Cell (2021-2026) & (US$/Unit)
Table 28. Global Sabin Inactivated Polio vaccine (sIPV) Sale by Application (2021-2026) & (K Dose)
Table 29. Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2021-2026)
Table 30. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2021-2026) & ($ million)
Table 31. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2021-2026)
Table 32. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Company (2021-2026) & (K Dose)
Table 34. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company (2021-2026)
Table 35. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company (2021-2026)
Table 37. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Producing Area Distribution and Sales Area
Table 39. Players Sabin Inactivated Polio vaccine (sIPV) Products Offered
Table 40. Sabin Inactivated Polio vaccine (sIPV) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Geographic Region (2021-2026) & (K Dose)
Table 44. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share Geographic Region (2021-2026)
Table 45. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Country/Region (2021-2026) & (K Dose)
Table 48. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country/Region (2021-2026)
Table 49. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026) & (K Dose)
Table 52. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2021-2026)
Table 53. Americas Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 55. Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 56. APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2021-2026) & (K Dose)
Table 57. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2021-2026)
Table 58. APAC Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 60. APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 61. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026) & (K Dose)
Table 62. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 64. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 65. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026) & (K Dose)
Table 66. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 68. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 69. Key Market Drivers & Growth Opportunities of Sabin Inactivated Polio vaccine (sIPV)
Table 70. Key Market Challenges & Risks of Sabin Inactivated Polio vaccine (sIPV)
Table 71. Key Industry Trends of Sabin Inactivated Polio vaccine (sIPV)
Table 72. Sabin Inactivated Polio vaccine (sIPV) Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Sabin Inactivated Polio vaccine (sIPV) Distributors List
Table 75. Sabin Inactivated Polio vaccine (sIPV) Customer List
Table 76. Global Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Region (2027-2032) & (K Dose)
Table 77. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Country (2027-2032) & (K Dose)
Table 79. Americas Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Region (2027-2032) & (K Dose)
Table 81. APAC Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Country (2027-2032) & (K Dose)
Table 85. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Type (2027-2032) & (K Dose)
Table 87. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Application (2027-2032) & (K Dose)
Table 89. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Sanofi Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 92. Sanofi Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. GSK Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 96. GSK Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 97. GSK Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. GSK Main Business
Table 99. GSK Latest Developments
Table 100. Serum Institute of India Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 101. Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 102. Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Serum Institute of India Main Business
Table 104. Serum Institute of India Latest Developments
Table 105. Bharat Biotech Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 106. Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 107. Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Bharat Biotech Main Business
Table 109. Bharat Biotech Latest Developments
Table 110. Bilthoven Biologicals Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 111. Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 112. Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Bilthoven Biologicals Main Business
Table 114. Bilthoven Biologicals Latest Developments
Table 115. Bio Farma Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 116. Bio Farma Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 117. Bio Farma Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Bio Farma Main Business
Table 119. Bio Farma Latest Developments
Table 120. Panacea Biotec Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 121. Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 122. Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Panacea Biotec Main Business
Table 124. Panacea Biotec Latest Developments
Table 125. Sinovac Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 126. Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 127. Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Sinovac Main Business
Table 129. Sinovac Latest Developments
Table 130. Beijing Tiantan Biological Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 131. Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 132. Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Beijing Tiantan Biological Main Business
Table 134. Beijing Tiantan Biological Latest Developments
Table 135. IMBCAMS Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 136. IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 137. IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. IMBCAMS Main Business
Table 139. IMBCAMS Latest Developments
Table 1. Sabin Inactivated Polio vaccine (sIPV) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sabin Inactivated Polio vaccine (sIPV) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vials
Table 4. Major Players of Syringes
Table 5. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 6. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Table 7. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2021-2026)
Table 9. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Monovalent
Table 11. Major Players of Bivalent
Table 12. Major Players of Trivalent
Table 13. Major Players of Multivalent
Table 14. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Valency (2021-2026) & (K Dose)
Table 15. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Valency (2021-2026)
Table 16. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Valency (2021-2026) & ($ million)
Table 17. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Valency (2021-2026)
Table 18. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Valency (2021-2026) & (US$/Unit)
Table 19. Major Players of Vero Cell
Table 20. Major Players of Human Diploid
Table 21. Major Players of Primary Cell
Table 22. Major Players of Recombinant
Table 23. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Production Cell (2021-2026) & (K Dose)
Table 24. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Production Cell (2021-2026)
Table 25. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Production Cell (2021-2026) & ($ million)
Table 26. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Production Cell (2021-2026)
Table 27. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Production Cell (2021-2026) & (US$/Unit)
Table 28. Global Sabin Inactivated Polio vaccine (sIPV) Sale by Application (2021-2026) & (K Dose)
Table 29. Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2021-2026)
Table 30. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2021-2026) & ($ million)
Table 31. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2021-2026)
Table 32. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Company (2021-2026) & (K Dose)
Table 34. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company (2021-2026)
Table 35. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company (2021-2026)
Table 37. Global Sabin Inactivated Polio vaccine (sIPV) Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Sabin Inactivated Polio vaccine (sIPV) Producing Area Distribution and Sales Area
Table 39. Players Sabin Inactivated Polio vaccine (sIPV) Products Offered
Table 40. Sabin Inactivated Polio vaccine (sIPV) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Geographic Region (2021-2026) & (K Dose)
Table 44. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share Geographic Region (2021-2026)
Table 45. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Country/Region (2021-2026) & (K Dose)
Table 48. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country/Region (2021-2026)
Table 49. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026) & (K Dose)
Table 52. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2021-2026)
Table 53. Americas Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 55. Americas Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 56. APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2021-2026) & (K Dose)
Table 57. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2021-2026)
Table 58. APAC Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 60. APAC Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 61. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026) & (K Dose)
Table 62. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 64. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 65. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2021-2026) & (K Dose)
Table 66. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2021-2026) & (K Dose)
Table 68. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2021-2026) & (K Dose)
Table 69. Key Market Drivers & Growth Opportunities of Sabin Inactivated Polio vaccine (sIPV)
Table 70. Key Market Challenges & Risks of Sabin Inactivated Polio vaccine (sIPV)
Table 71. Key Industry Trends of Sabin Inactivated Polio vaccine (sIPV)
Table 72. Sabin Inactivated Polio vaccine (sIPV) Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Sabin Inactivated Polio vaccine (sIPV) Distributors List
Table 75. Sabin Inactivated Polio vaccine (sIPV) Customer List
Table 76. Global Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Region (2027-2032) & (K Dose)
Table 77. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Country (2027-2032) & (K Dose)
Table 79. Americas Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Region (2027-2032) & (K Dose)
Table 81. APAC Sabin Inactivated Polio vaccine (sIPV) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Country (2027-2032) & (K Dose)
Table 85. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Type (2027-2032) & (K Dose)
Table 87. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Sabin Inactivated Polio vaccine (sIPV) Sales Forecast by Application (2027-2032) & (K Dose)
Table 89. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Sanofi Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 92. Sanofi Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. GSK Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 96. GSK Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 97. GSK Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. GSK Main Business
Table 99. GSK Latest Developments
Table 100. Serum Institute of India Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 101. Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 102. Serum Institute of India Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Serum Institute of India Main Business
Table 104. Serum Institute of India Latest Developments
Table 105. Bharat Biotech Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 106. Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 107. Bharat Biotech Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Bharat Biotech Main Business
Table 109. Bharat Biotech Latest Developments
Table 110. Bilthoven Biologicals Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 111. Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 112. Bilthoven Biologicals Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Bilthoven Biologicals Main Business
Table 114. Bilthoven Biologicals Latest Developments
Table 115. Bio Farma Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 116. Bio Farma Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 117. Bio Farma Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Bio Farma Main Business
Table 119. Bio Farma Latest Developments
Table 120. Panacea Biotec Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 121. Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 122. Panacea Biotec Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Panacea Biotec Main Business
Table 124. Panacea Biotec Latest Developments
Table 125. Sinovac Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 126. Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 127. Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Sinovac Main Business
Table 129. Sinovac Latest Developments
Table 130. Beijing Tiantan Biological Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 131. Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 132. Beijing Tiantan Biological Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Beijing Tiantan Biological Main Business
Table 134. Beijing Tiantan Biological Latest Developments
Table 135. IMBCAMS Basic Information, Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base, Sales Area and Its Competitors
Table 136. IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Product Portfolios and Specifications
Table 137. IMBCAMS Sabin Inactivated Polio vaccine (sIPV) Sales (K Dose), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. IMBCAMS Main Business
Table 139. IMBCAMS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sabin Inactivated Polio vaccine (sIPV)
Figure 2. Sabin Inactivated Polio vaccine (sIPV) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sabin Inactivated Polio vaccine (sIPV) Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sabin Inactivated Polio vaccine (sIPV) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country/Region (2025)
Figure 10. Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vials
Figure 12. Product Picture of Syringes
Figure 13. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type in 2026
Figure 14. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Monovalent
Figure 16. Product Picture of Bivalent
Figure 17. Product Picture of Trivalent
Figure 18. Product Picture of Multivalent
Figure 19. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Valency in 2026
Figure 20. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Valency (2021-2026)
Figure 21. Product Picture of Vero Cell
Figure 22. Product Picture of Human Diploid
Figure 23. Product Picture of Primary Cell
Figure 24. Product Picture of Recombinant
Figure 25. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Production Cell in 2026
Figure 26. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Production Cell (2021-2026)
Figure 27. Sabin Inactivated Polio vaccine (sIPV) Consumed in Hospitals
Figure 28. Global Sabin Inactivated Polio vaccine (sIPV) Market: Hospitals (2021-2026) & (K Dose)
Figure 29. Sabin Inactivated Polio vaccine (sIPV) Consumed in Clinics
Figure 30. Global Sabin Inactivated Polio vaccine (sIPV) Market: Clinics (2021-2026) & (K Dose)
Figure 31. Sabin Inactivated Polio vaccine (sIPV) Consumed in Others
Figure 32. Global Sabin Inactivated Polio vaccine (sIPV) Market: Others (2021-2026) & (K Dose)
Figure 33. Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2025)
Figure 34. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application in 2025
Figure 35. Sabin Inactivated Polio vaccine (sIPV) Sales by Company in 2025 (K Dose)
Figure 36. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company in 2025
Figure 37. Sabin Inactivated Polio vaccine (sIPV) Revenue by Company in 2025 ($ millions)
Figure 38. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company in 2025
Figure 39. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 42. Americas Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 43. APAC Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 44. APAC Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 45. Europe Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 46. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 48. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 49. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country in 2025
Figure 50. Americas Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2021-2026)
Figure 51. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 52. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 53. United States Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region in 2025
Figure 58. APAC Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2021-2026)
Figure 59. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 60. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 61. China Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 65. India Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country in 2025
Figure 69. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2021-2026)
Figure 70. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 71. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 72. Germany Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 73. France Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 80. Egypt Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Sabin Inactivated Polio vaccine (sIPV) in 2026
Figure 86. Manufacturing Process Analysis of Sabin Inactivated Polio vaccine (sIPV)
Figure 87. Industry Chain Structure of Sabin Inactivated Polio vaccine (sIPV)
Figure 88. Channels of Distribution
Figure 89. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Forecast by Region (2027-2032)
Figure 90. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Sabin Inactivated Polio vaccine (sIPV)
Figure 2. Sabin Inactivated Polio vaccine (sIPV) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sabin Inactivated Polio vaccine (sIPV) Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sabin Inactivated Polio vaccine (sIPV) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country/Region (2025)
Figure 10. Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vials
Figure 12. Product Picture of Syringes
Figure 13. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type in 2026
Figure 14. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Monovalent
Figure 16. Product Picture of Bivalent
Figure 17. Product Picture of Trivalent
Figure 18. Product Picture of Multivalent
Figure 19. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Valency in 2026
Figure 20. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Valency (2021-2026)
Figure 21. Product Picture of Vero Cell
Figure 22. Product Picture of Human Diploid
Figure 23. Product Picture of Primary Cell
Figure 24. Product Picture of Recombinant
Figure 25. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Production Cell in 2026
Figure 26. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Production Cell (2021-2026)
Figure 27. Sabin Inactivated Polio vaccine (sIPV) Consumed in Hospitals
Figure 28. Global Sabin Inactivated Polio vaccine (sIPV) Market: Hospitals (2021-2026) & (K Dose)
Figure 29. Sabin Inactivated Polio vaccine (sIPV) Consumed in Clinics
Figure 30. Global Sabin Inactivated Polio vaccine (sIPV) Market: Clinics (2021-2026) & (K Dose)
Figure 31. Sabin Inactivated Polio vaccine (sIPV) Consumed in Others
Figure 32. Global Sabin Inactivated Polio vaccine (sIPV) Market: Others (2021-2026) & (K Dose)
Figure 33. Global Sabin Inactivated Polio vaccine (sIPV) Sale Market Share by Application (2025)
Figure 34. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application in 2025
Figure 35. Sabin Inactivated Polio vaccine (sIPV) Sales by Company in 2025 (K Dose)
Figure 36. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Company in 2025
Figure 37. Sabin Inactivated Polio vaccine (sIPV) Revenue by Company in 2025 ($ millions)
Figure 38. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Company in 2025
Figure 39. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 42. Americas Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 43. APAC Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 44. APAC Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 45. Europe Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 46. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales 2021-2026 (K Dose)
Figure 48. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue 2021-2026 ($ millions)
Figure 49. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country in 2025
Figure 50. Americas Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2021-2026)
Figure 51. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 52. Americas Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 53. United States Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region in 2025
Figure 58. APAC Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2021-2026)
Figure 59. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 60. APAC Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 61. China Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 65. India Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country in 2025
Figure 69. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2021-2026)
Figure 70. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 71. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 72. Germany Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 73. France Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2021-2026)
Figure 80. Egypt Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Sabin Inactivated Polio vaccine (sIPV) Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Sabin Inactivated Polio vaccine (sIPV) in 2026
Figure 86. Manufacturing Process Analysis of Sabin Inactivated Polio vaccine (sIPV)
Figure 87. Industry Chain Structure of Sabin Inactivated Polio vaccine (sIPV)
Figure 88. Channels of Distribution
Figure 89. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Forecast by Region (2027-2032)
Figure 90. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share Forecast by Application (2027-2032)
